Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.Patterns (New York, N.Y.)|November 24, 2022
A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI imagesQing Lyu, Sanjeev V Namjoshi, Emory McTyre, et al.Neuroradiology|August 11, 2018
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?Michael H Soike, Emory R McTyre, Nameeta Shah, et al.Cancers|March 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?Sarah E Glynn, Claire M Lanier, Ariel R Choi, et al.The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.JCI Insight|April 14, 2017
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's diseaseMartin Niethammer, Chris C Tang, Peter A LeWitt, et al.Neuro-Oncology Advances|May 25, 2022
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastomaJohn F de Groot, Albert H Kim, Sujit Prabhu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.Journal of Neuro-Oncology|August 23, 2017
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogramDiandra N Ayala-Peacock, Albert Attia, Steve E Braunstein, et al.JAMA Neurology|September 15, 2025
Five-Year Outcomes from Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson DiseasePhilip A Starr, Rajat S Shivacharan, Edward Goldberg, et al.Pageof 17